These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 31082791)
1. FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma. Zhi Y; Abudoureyimu M; Zhou H; Wang T; Feng B; Wang R; Chu X Mol Ther Nucleic Acids; 2019 Jun; 16():576-588. PubMed ID: 31082791 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression. Chen Y; Shen Z; Zhi Y; Zhou H; Zhang K; Wang T; Feng B; Chen Y; Song H; Wang R; Chu X Arch Biochem Biophys; 2018 May; 645():117-125. PubMed ID: 29559320 [TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. Takahashi K; Yan IK; Kogure T; Haga H; Patel T FEBS Open Bio; 2014; 4():458-67. PubMed ID: 24918061 [TBL] [Abstract][Full Text] [Related]
4. Linc-ROR drive adriamycin resistance by targeting AP-2α/Wnt/β-catenin axis in hepatocellular carcinoma. Shi CJ; Lv MY; Deng LQ; Zeng WQ; Fu WM; Zhang JF Cell Biol Toxicol; 2023 Aug; 39(4):1735-1752. PubMed ID: 36576707 [TBL] [Abstract][Full Text] [Related]
5. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway. Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051 [TBL] [Abstract][Full Text] [Related]
6. Linc-ROR Regulates Yu X; Ma X; Jia Y; Wu X; Yan Z Cell Transplant; 2023; 32():9636897231178902. PubMed ID: 37306240 [TBL] [Abstract][Full Text] [Related]
7. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers. Pan Y; Li C; Chen J; Zhang K; Chu X; Wang R; Chen L Cell Physiol Biochem; 2016; 40(1-2):219-229. PubMed ID: 27855392 [TBL] [Abstract][Full Text] [Related]
8. Emerging Roles of Long Noncoding RNA Regulator of Reprogramming in Cancer Treatment. Sun DE; Ye SY Cancer Manag Res; 2020; 12():6103-6112. PubMed ID: 32765105 [TBL] [Abstract][Full Text] [Related]
9. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma. Sahebi R; Malakootian M; Balalaee B; Shahryari A; Khoshnia M; Abbaszadegan MR; Moradi A; Javad Mowla S Iran J Basic Med Sci; 2016 Oct; 19(10):1131-1135. PubMed ID: 27872710 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536 [TBL] [Abstract][Full Text] [Related]
11. Relevance Function of Linc-ROR in the Pathogenesis of Cancer. Chen W; Yang J; Fang H; Li L; Sun J Front Cell Dev Biol; 2020; 8():696. PubMed ID: 32850817 [TBL] [Abstract][Full Text] [Related]
12. Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance. Peña-Flores JA; Enríquez-Espinoza D; Muela-Campos D; Álvarez-Ramírez A; Sáenz A; Barraza-Gómez AA; Bravo K; Estrada-Macías ME; González-Alvarado K Noncoding RNA; 2023 Jan; 9(1):. PubMed ID: 36827545 [TBL] [Abstract][Full Text] [Related]
13. FOXM1 Promotes Head and Neck Squamous Cell Carcinoma Ma X; Zhang H; Li Q; Schiferle E; Qin Y; Xiao S; Li T Front Oncol; 2021; 11():658712. PubMed ID: 34447693 [TBL] [Abstract][Full Text] [Related]
14. The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4. Li X; Chen W; Jia J; You Z; Hu C; Zhuang Y; Lin Z; Liu Y; Yang C; Xu R Onco Targets Ther; 2020; 13():2573-2581. PubMed ID: 32273727 [TBL] [Abstract][Full Text] [Related]
15. A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth. Chen F; Bai G; Li Y; Feng Y; Wang L Am J Cancer Res; 2017; 7(7):1423-1434. PubMed ID: 28744394 [TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA Linc-USP16 Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Regulating PTEN Expression. Sui J; Yang X; Qi W; Guo K; Gao Z; Wang L; Sun D Cell Physiol Biochem; 2017; 44(3):1188-1198. PubMed ID: 29179215 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of LINC-ROR in cancer cell lines and tissues. Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857 [TBL] [Abstract][Full Text] [Related]
18. Linc-ROR Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Functioning as a Competing Endogenous RNA for miR-138 and miR-145. Feng L; Shi L; Lu YF; Wang B; Tang T; Fu WM; He W; Li G; Zhang JF Mol Ther Nucleic Acids; 2018 Jun; 11():345-353. PubMed ID: 29858070 [TBL] [Abstract][Full Text] [Related]
19. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling. Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257 [TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma. Fawzy MS; Toraih EA; El-Wazir A; Hosny MM; Badran DI; El Kelish A Arch Med Sci; 2021; 17(4):1016-1027. PubMed ID: 34336029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]